Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;74(5):1246-1248.
doi: 10.1016/j.jhep.2020.12.018. Epub 2020 Dec 20.

Impact of the COVID-19 pandemic on HCV elimination in Spain

Maria Buti  1 , Raquel Domínguez-Hernández  2 , Miguel Angel Casado  2
Affiliations
Comment

Impact of the COVID-19 pandemic on HCV elimination in Spain

Maria Buti et al. J Hepatol. 2021 May.
No abstract available

Keywords: COVID-19; Elimination; HCV.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest MB: Advisory Board participant for Gilead and Abbvie. RDH and MAC are employees of Pharmacoeconomics & Outcomes Research Iberia, a consultancy firm specialising in the economic evaluation of healthcare interventions that has received unconditional funding from Gilead Sciences. Please refer to the accompanying ICMJE disclosure forms for further details.

Figures

Fig. 1
Fig. 1
Impact of the COVID-19-related diagnostic and treatment delay on HCV burden (clinical and economic) over the next 10 years.
See this image and copyright information in PMC

Comment on

  • Impact of COVID-19 on global HCV elimination efforts.
    Blach S, Kondili LA, Aghemo A, Cai Z, Dugan E, Estes C, Gamkrelidze I, Ma S, Pawlotsky JM, Razavi-Shearer D, Razavi H, Waked I, Zeuzem S, Craxi A. Blach S, et al. J Hepatol. 2021 Jan;74(1):31-36. doi: 10.1016/j.jhep.2020.07.042. Epub 2020 Aug 7. J Hepatol. 2021. PMID: 32777322 Free PMC article.

References

    1. Blach S., Kondili L.A., Aghemo A., Cai Z., Dugan E., Estes C., et al. Impact of COVID-19 on global HCV elimination efforts. J Hepatol. 2021;74:31–36. - PMC - PubMed
    1. Razavi H., Pawlotsky J.M., Lazarus J.V., Feld J., Bao Y., Pires dos Santos A.G., et al. Poster presented in The Digital International Liver Congress. 2020. Global timing of hepatitis C virus elimination in high-income countries: an updated analysis. THU365.
    1. Picchio C.A., Valencia J., Doran J., Swan T., Pastor M., Martró E., et al. The impact of the COVID-19 pandemic on harm reduction services in Spain. Harm Reduct J. 2020;17:87. - PMC - PubMed
    1. Turnes J., Domínguez-Hernández R., Casado M.Á. Cost-effectiveness analysis of two treatment strategies for chronic hepatitis C before and after access to direct-acting antivirals in Spain. Gastroenterol Hepatol. 2017;40:433–446. - PubMed
    1. Plan Estratégico para el abordaje de la Hepatitis C en el SNS (PEAHC) October 2020. Ministerio de Sanidad, Consumo y Bienestar Social.https://www.mscbs.gob.es/ciudadanos/enfLesiones/enfTransmisibles/hepatit... Available in: